Literature DB >> 2722886

Identification of two distinct isoforms of stathmin and characterization of their respective phosphorylated forms.

L Beretta1, F Houdouin, A Sobel.   

Abstract

Stathmin is a ubiquitous soluble protein (Mr approximately 19,000, pI approximately 6.2-5.5) whose phosphorylation is associated with the intracellular mechanisms involved in the regulations of cell differentiation and functions by extracellular effectors. Its purification from rat brain and the preparation of specific antibodies allowed us to identify a set of immunologically related unphosphorylated (N1, N2) and phosphorylated (P1, P2a, P2b, P3) proteins of decreasing isoelectric points. All these proteins yielded identical silver-stained or 32P-radioactive peptide maps with the protease V8 from Staphylococcus aureus, indicating that they are also structurally related. In vitro phosphorylation with the exogenous catalytic subunit of the cAMP-dependent protein kinase, as well as dephosphorylation with alkaline phosphatase, indicated that P1, P2, and P3 derived from N1 and N2 by progressive phosphorylation. Phosphorylation of individual proteins extracted from semi-preparative two-dimensional polyacrylamide gels demonstrated the existence of two distinct isoforms of stathmin, alpha and beta: N1 and N2 are their respective unphosphorylated forms (alpha O and beta O), whereas proteins P1-P3 could be resolved as at least three increasingly phosphorylated forms of both alpha and beta stathmin (alpha 1, alpha 2, alpha(3) and beta 1, beta 2, beta(3]. In intact pituitary GH4C1 cells, hormones like thyrotropin-releasing hormone and vasoactive intestinal peptide induced a similar conversion from N1 and N2 to P1, P2, and P3. The phosphorylation of both alpha and beta isoforms of stathmin is therefore a physiologically significant response to specific extracellular regulatory agents. In conclusion, stathmin represents a family of at least two distinct protein isoforms, whose respective phosphorylation and expression might play a role in its likely function as an intracellular relay of various converging extracellular signals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722886

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Stathmin levels in growth plate chondrocytes are modulated by vitamin D3 metabolites and transforming growth factor-beta1 and are associated with proliferation.

Authors:  T W Hummert; Z Schwartz; V L Sylvia; D D Dean; B D Boyan
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.

Authors:  W Schledermann; I Wulfsen; J R Schwarz; C K Bauer
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

3.  Expression of transfected stathmin cDNA reveals novel phosphorylated forms associated with developmental and functional cell regulation.

Authors:  V Doye; S Le Gouvello; T Dobransky; H Chneiweiss; L Beretta; A Sobel
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

4.  Molecular characterization of human stathmin expressed in Escherichia coli: site-directed mutagenesis of two phosphorylatable serines (Ser-25 and Ser-63).

Authors:  P A Curmi; A Maucuer; S Asselin; M Lecourtois; A Chaffotte; J M Schmitter; A Sobel
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

5.  Overexpression of the stathmin gene in a subset of human breast cancer.

Authors:  I Bièche; S Lachkar; V Becette; C Cifuentes-Diaz; A Sobel; R Lidereau; P A Curmi
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.